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Abstract In the perfused rat liver, the anaphylatoxin C5a has
been shown to enhance glucose output. Since hepatocytes lack
C5a receptor mRNA, the metabolic effect of C5a must be elicited
indirectly via C5a receptor expressing non-parenchymal liver
cells. Kupffer cells were found to be able to mediate the C5a
action via release of prostanoids. However, elimination of the
Kupffer cells by pretreatment of the animals with gadolinium
chloride reduced the metabolic effect of C5a to only about 40%.
Therefore, it was investigated whether not only Kupffer cells but
in addition also hepatic stellate cells or sinusoidal endothelial
cells released prostanoids in response to C5a. In isolated hepatic
stellate cells but not in sinusoidal endothelial cells, recombinant
rat C5a induced a time- and dose-dependent release of
thromboxane B2 and prostaglandins D2, E2 and F2K. The rate
of prostanoid release was maximal within the first two minutes
and then declined again. C5a-induced prostanoid release from
hepatic stellate cells was smaller than that from Kupffer cells and
it differed in the prostanoid ratios (PGE2/PGD2/PGF2K/
TXB2 = 1:1:0.1:0.6 and 1:4:1:3, respectively). RrC5a activated
hepatocellular glycogen phosphorylase via prostanoid release in
cocultures of hepatocytes with hepatic stellate cells but not with
sinusoidal endothelial cells. Thus, the part of the rrC5a-induced
glucose output in the perfused rat liver, which was not abrogated
by elimination of the Kupffer cells with gadolinium chloride, most
likely was mediated by prostanoids released from hepatic stellate
cells.
z 1998 Federation of European Biochemical Societies.
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1. Introduction
The anaphylatoxins C3a and C5a are generated during
complement activation via the classical or the alternative
pathway. The peptides are derived from the N-terminal 74^
77 amino acid residues of the K-chains of the complement
proteins C3 and C5 [1^4]. Various actions of anaphylatoxins
on myeloid blood cells have long been known such as the
release of histamine from mast cells or the chemotaxis and
activation of neutrophils. The latter is characterized by inva-
sion of the cells into the in£amed tissue and the local release
of reactive oxygen species, cytokines and eicosanoids. More-
over, anaphylatoxins induce an enhanced permeability of
blood vessels and the contraction of smooth muscle cells [5^7].
In the perfused rat liver, recombinant rat C5a (rrC5a) en-
hanced glucose release and reduced £ow [8,9]. The enhanced
glucose release cannot be explained by a direct action of rrC5a
on the hepatocytes (HC), since these cells do not express C5a
receptor (C5aR) mRNA [10]. Thus, this e¡ect must be medi-
ated indirectly by action of rrC5a on the C5aR mRNA ex-
pressing non-parenchymal liver cells, i.e. Kup¡er cells (KC),
hepatic stellate cells (HSC) or sinusoidal endothelial cells
(SEC) [10], which then release a mediator capable of activat-
ing glycogen phosphorylase in hepatocytes. Two observations
were in line with this assumption: (i) the metabolic and he-
modynamic e¡ects of rrC5a in the perfused rat liver were
inhibited by the prostanoid synthesis inhibitor indomethacin
[9] ; (ii) rrC5a induced a prostanoid-dependent increase in gly-
cogen phosphorylase activity in cocultures of Kup¡er cells
with hepatocytes but not in hepatocytes alone [11]. These
results indicated that the metabolic and hemodynamic e¡ects
of rrC5a were mainly mediated by prostanoids released from
Kup¡er cells. Nevertheless, in perfused rat livers in which the
Kup¡er cells had been eliminated by pretreatment of the ani-
mals with gadolinium chloride, the rrC5a-induced metabolic
and hemodynamic changes were inhibited to only about 40%
[8]. Thus, most likely another cell type besides Kup¡er cells
was involved in rrC5a-induced glucose output and £ow reduc-
tion.
Besides the Kup¡er cells, also hepatic stellate cells strongly
and sinusoidal endothelial cells weakly expressed C5aR
mRNA [10]. Hepatic stellate cells and sinusoidal endothelial
cells both have been shown to release prostaglandins after
stimulation with various stimuli such as the neurotransmitters
noradrenaline and ATP [12] or LPS [13] and ATP [14], re-
spectively.
It was the aim of this study to investigate whether besides
Kup¡er cells also hepatic stellate cells or sinusoidal endothe-
lial cells are involved in the anaphylatoxin-induced glucose
output in the perfused rat liver by releasing prostanoids. It
was shown that rrC5a induced the release of prostaglandins
and thromboxane from hepatic stellate cells but not from
sinusoidal endothelial cells and that the amounts of prosta-
glandins released were su⁄cient for the activation of glycogen
phosphorylase in cocultures of hepatic stellate cells with hep-
atocytes.
FEBS 20752 3-9-98
0014-5793/98/$19.00 ß 1998 Federation of European Biochemical Societies. All rights reserved.
PII: S 0 0 1 4 - 5 7 9 3 ( 9 8 ) 0 0 9 9 0 - 9
*Corresponding author. Fax: (49) (551) 39 5960.
E-mail: hschief@gwdg.de
Abbreviations: rrC5a, recombinant rat C5a; C5aR, C5a receptor; PG,
prostaglandins; TX, thromboxane; NPC, non-parenchymal liver cells;
HC, hepatocytes; KC, Kupffer cells ; HSC, hepatic stellate cells ; SEC,
sinusoidal endothelial cells ; GPH, glycogen phosphorylase; HBSS,
Hanks’ balanced salt solution
FEBS 20752 FEBS Letters 434 (1998) 245^250
2. Materials and methods
2.1. Animals
Male Wistar rats (Winkelmann, Borchen, Germany, 150^200 g
for the perfusion experiments, 350^450 g for the isolation of KC,
HSC and SEC, 200^250 g for HC) were kept on a 12-h day/night
rhythm with free access to water and a standard rat diet (Ssni¡,
Soest) for at least 2 weeks before the experiments. Treatment of
the animals followed the German Law on the Protection of Animals
and was performed with permission of the state animal welfare com-
mittee.
2.2. Chemicals
All chemicals were of analytical grade and from commercial sour-
ces. Radio-immunoassays for PGD2 and PGF2K were from Amer-
sham (Braunschweig, Germany), enzyme immunoassays for TXB2
(the stable biologically inactive metabolite of TXA2) and PGE2
were from RpD Systems (Wiesbaden-Nordenstadt, Germany). Pro-
nase was obtained from Merck (Darmstadt, Germany), collagenase H
and DNase from Boehringer Mannheim (Mannheim, Germany), Ny-
codenz from Life Technologies (Eggenstein, Germany) and Percoll
from Pharmacia (Freiburg, Germany). RPMI 1640 was purchased
from Biochrom (Berlin, Germany) and M199 from AppliChem
(Darmstadt, Germany). Newborn calf serum (NCS) was from PAA
Laboratories (Coº lbe, Germany), insulin and noradrenaline from Serva
(Heidelberg, Germany). Bis-benzimide, indomethacin and gadolinium
chloride were purchased from Sigma-Aldrich (Deisenhofen, Germany)
and tissue culture dishes were obtained from Nunc (Wiesbaden, Ger-
many).
2.3. Preparation of rrC5a
RrC5a was prepared by synthesis of a cDNA from rat liver RNA
and a subsequent PCR using degenerate 5P and 3P primers that were
designed according to sequence data published in the Swiss-Prot pro-
tein sequence data bank (accession no. P08650, ID: C05A_RAT) [15]
as described previously [4,11]. RrC5a contained in addition to the
original sequence of amino acids 1^77 the N-terminal sequence
MRGJHHHHHHGI used for its puri¢cation from bacterial lysates
by Ni2-chelate chromatography and was depleted of endotoxins by
a⁄nity chromatography on polymyxin B agarose.
2.4. Cell preparation
Hepatocytes were prepared by collagenase perfusion of rat liver.
Viable hepatocytes were obtained by removing detritus in two sub-
sequent washing steps with centrifugation at 50Ug and a ¢nal cen-
trifugation through 58% Percoll. Kup¡er cells and sinusoidal endo-
thelial cells were isolated by combined pronase/collagenase perfusion
and puri¢ed by Nycodenz density gradient centrifugation and subse-
quent counter£ow elutriation using a Beckman JE-6 elutriation rotor
in a J-21 Beckman centrifuge [16,17]. HSC were obtained by enzy-
matic digestion of the liver with pronase and collagenase essentially as
described in [18] with some minor modi¢cations (N. Kawada, person-
al communication). The resulting cell suspension, subsequently
handled at 4‡C, was ¢ltered through nylon gauze (mesh diameter
60 Wm) and centrifuged for 10 min at 450Ug. After 2 washing steps,
cells were resuspended in Hanks’ balanced salt solution (HBSS),
mixed with Nycodenz to a ¢nal concentration of 8.13% and overlaid
with HBSS. After centrifugation for 20 min at 1400Ug HSC were
obtained from the interphase. Purity of HSC as identi¢ed on the basis
of their typical light microscopic appearance and their vitamin
A-speci¢c auto£uorescence was about 95% after 24 h and s 98% after
48 h.
2.5. Non-parenchymal liver cell culture
Kup¡er cells were plated at 4U106 cells/plate, sinusoidal endothe-
lial cells at 8U106 cells/plate and hepatic stellate cells at 2.5U106 cells/
plate on 3.5-cm diameter tissue culture plates in RPMI 1640 (KC and
HSC) or M199 (SEC), each supplemented with 30% NCS and 1%
penicillin/streptomycin. For SEC cultures and cocultures (see below)
plates were coated with rat tail collagen prepared as in [19]. Cells were
cultured for 48 h (SEC and HSC) or 72 h (KC) before the experiments
unless indicated otherwise with medium changes every 24 h. For elim-
ination of possibly remaining KC in HSC, cultures were treated with
10 WM gadolinium chloride for 24 h before the start of the experi-
ments where indicated.
2.6. Hepatocyte culture
Hepatocytes were plated at 5U105 cells/plate on 3.5-cm diameter
collagenated (see Section 2.5) tissue culture plates in M199 supple-
mented with 10% NCS, 0.5 nM insulin and 1% penicillin/streptomycin
for 24 h before the experiment with one medium change after 4 h.
2.7. Cocultures
For cocultures with hepatocytes, Kup¡er cells were seeded at
3U106 cells/plate in RPMI 1640, sinusoidal endothelial cells at
6U106 cells/plate in M199 and hepatic stellate cells at 2U106 cells/
plate in RPMI 1640 on 3.5-cm diameter collagenated (see Section 2.5)
tissue culture plates. All media were supplemeted with 30% NCS and
1% penicillin/streptomycin. Medium was changed after 24 h. After 24
h (HSC and SEC) or 48 h (KC) freshly prepared hepatocytes (5U105
cells/plate) were plated on top of the HSC, SEC or KC. Cocultures
were incubated in M199 supplemented with 10% NCS, 0.5 nM insulin
and 1% penicillin/streptomycin for another 24 h with one medium
change after 4 h.
2.8. Detection of C5aR mRNA in hepatic stellate cells by quantitative
reverse transcriptase-polymerase chain reaction (RT-PCR)
Total RNA from freshly isolated and cultured HSC was isolated by
an RNeasy Kit provided by Qiagen (Hilden, Germany). Six Wg total
RNA were preincubated for 10 min at 68‡C with 500 ng oligo-
d(T)12ÿ18 and transcribed with reverse transcriptase (Superscript II,
Gibco, Eggenstein, Germany) at 45‡C into cDNA. cDNAs thus gen-
erated were ampli¢ed in a 50-Wl reaction mix with foreward and re-
verse oligonucleotide primers rC5aR-F and rC5aR-R (positions 267^
287 and 777^756 according to the sequence published under GenBank
accession no. Y09613) or r-beta-actin-F and r-beta-actin-R (positions
1251^1271 and 2570^2553, GenBank accession no. J00691) in the
presence or absence of an internal standard for quanti¢cation as de-
scribed in detail in [10].
2.9. Determination of prostanoid formation in hepatic stellate cells and
sinusoidal endothelial cells
At the indicated times, cells were washed three times with HBSS,
supplemented with 20 mM HEPES, pH 7.4, and preincubated at 37‡C
for 5 min in HEPES-bu¡ered HBSS and for another 5 min in HEPES-
bu¡ered HBSS with or without 20 WM indomethacin in 0.1% DMSO.
After 10 min preincubation rrC5a was added to the ¢nal concentra-
tion indicated, normally 100 nM (= 1 Wg/ml). Immediately after addi-
tion and at the time points indicated, samples of the medium were
taken from the supernatant and shock frozen in liquid nitrogen for
the later determination of prostanoid concentrations. Prostanoids
were determined by radio- or enzyme immunoassays without further
puri¢cation according to the instructions of the manufacturers. At the
end of the experiment, cells were scraped o¡ the dish for DNA deter-
mination in a £uorescence assay based on the intercalation of bis-
benzimide into DNA [20].
2.10. Determination of glycogen phosphorylase activity in mono- and
cocultures
Mono- and cocultures were washed three times with HEPES-buf-
fered saline (20 mM HEPES, 120 mM NaCl, 4.8 mM KCl, 1.2 mM
MgSO4, 1.2 mM KH2PO4; 2.5 mM CaCl2, 5 mM glucose, 2 mM
lactate and 0.2 mM pyruvate, pH 7.4). Cells were incubated for
5 min at 37‡C in the same bu¡er and for another 5 min in the
same bu¡er with or without 20 WM indomethacin in 0.1% DMSO.
The medium was then discarded and replaced with HEPES-bu¡ered
saline containing rrC5a (¢nal concentration 100 nM = 1 Wg/ml) or
noradrenaline (1 WM). After 2 min of incubation the bu¡er was
removed and the plates were frozen in liquid nitrogen. Cells were
scraped o¡ the dishes and glycogen phosphorylase activity was deter-
mined by a standard assay [21].
3. Results and discussion
3.1. C5a receptor mRNA expression in cultured hepatic stellate
cells and sinusoidal endothelial cells
The possible C5a-elicited release of prostanoids from hep-
atic stellate cells or sinusoidal endothelial cells cannot be in-
vestigated in freshly isolated cells, since during the isolation of
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non-parenchymal cells by enzymatic digestion of the liver tis-
sue ectocellular receptors can be damaged to varying degrees.
The problem can be studied in cultured cells, because the
receptors are normally re-expressed during culture. Since so
far C5aR mRNA expression has only been studied in freshly
isolated cells [10], it was ¢rst investigated whether hepatic
stellate cells or sinusoidal endothelial cells modulated C5aR
mRNA expression during the culture period of up to 72 h.
This control investigation was also mandatory, because espe-
cially hepatic stellate cells might change their state of di¡er-
entiation [22] and their state of receptor expression during
culture. With quantitative RT-PCR it was demonstrated
that the expression of C5aR mRNA did not vary between
freshly isolated hepatic stellate cells and cells cultured for 24
h, 48 h and 72 h (not shown). Also the low level C5aR mRNA
expression in sinusoidal endothelial cells cultured for 48 h did
not di¡er from that found in freshly isolated cells (not shown).
Moreover, Kup¡er cells, which in contrast to hepatic stellate
cells and sinusoidal endothelial cells can easily be detached
from the tissue culture plates, have been shown by £ow cy-
tometry to fully re-express C5aR protein after 48 h of culture
(unpublished observations). Similar kinetics of C5aR protein
re-expression can be expected for hepatic stellate cells and
sinusoidal endothelial cells.
3.2. Increase by rrC5a of prostanoid release from cultured
hepatic stellate cells but not sinusoidal endothelial cells
RrC5a (100 nM) induced the release of TXB2 (the stable
product of the actually released but unstable TXA2), PGD2,
PGE2 and PGF2K within 10 min from hepatic stellate cells
cultured for 48 h (Fig. 1). With cells cultured for 72 h the
rate of rrC5a-elicited prostanoid formation did not di¡er sig-
ni¢cantly from that in cells cultured for 48 h (not shown).
This was in contrast to prostaglandin release from hepatic
stellate cells elicited by noradrenaline or ATP, which was
found to be maximal after 24 h and not detectable after 72
h [12]. These di¡erences might be due to di¡erences in the
turnover rates of the respective receptors and/or di¡erences
in the modulation of receptor expression during cell culture.
RrC5a failed to induce a release of PGD2 and PGE2 from
sinusoidal endothelial cells cultured for 48 h (Fig. 1). Thus,
sinusoidal endothelial cells do not seem to be involved as a
source of prostanoids in short-term defense reactions of the
liver in response to C5a.
Hepatic stellate cells released less prostanoids upon stimu-
lation with rrC5a than Kup¡er cells. Moreover, the ratios of
prostanoid output were di¡erent: while hepatic stellate cells
and Kup¡er cells released similar absolute amounts of PGE2,
the relative amounts of PGE2/PGD2/PGF2K/TXB2 were
1:1:0.1:0.6 with hepatic stellate cells (Fig. 1) and 1:4:1:3
with Kup¡er cells [11]. Thromboxane and the various prosta-
glandins have distinct functions within the liver tissue and
with each liver cell type, since Kup¡er cells, hepatic stellate
cells, sinusoidal endothelial cells and hepatocytes express
characteristic sets of prostanoid receptors [23]. Therefore,
the di¡erent ratios of prostanoids released from Kup¡er cells
and hepatic stellate cells after stimulation with rrC5a might
re£ect di¡erent functions of these cells in the regulation of
defense reactions of the liver during in£ammation (see below).
After a single application of 100 nM rrC5a the levels of
TXB2, PGD2 and PGE2 increased over 5 min and then re-
mained almost constant for another 5 min. As has been de-
scribed for Kup¡er cells [11], the rate of prostanoid release
was maximal within the ¢rst 2 min (Fig. 2). Thus, rrC5a-
induced prostanoid release from hepatic stellate cells was rap-
id enough for the mediation of anaphylatoxin-induced glucose
output in the perfused rat liver, which was maximal already
2^3 min after infusion of rrC5a [8].
Low levels of rrC5a (1 nM and 10 nM) increased prosta-
noid production only slightly, but medium levels of rrC5a
(100 nM) elicited a signi¢cant release of TXB2, PGD2 and
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Fig. 1. Increase by rrC5a of TXB2, PGD2, PGE2 and PGF2K release
from cultured hepatic stellate cells and Kup¡er cells but not sinusoi-
dal endothelial cells. Hepatic stellate cells, sinusoidal endothelial
cells and Kup¡er cells were isolated and cultured for 48 h (HSC
and SEC) or 72 h (KC) as described in Section 2. After three
washes in HEPES-bu¡ered HBSS, cells were preincubated for 10 min
in the same bu¡er and then stimulated with rrC5a at a ¢nal concen-
tration of 100 nM (= 1 Wg/ml). Supernatants were removed after
10 min and increases in prostanoid concentrations over basal levels
at 0 min were determined by radio- or enzyme immunoassays. Val-
ues are means þ S.E.M. of the number of experiments given in pa-
rentheses. *P9 0.01, signi¢cant di¡erences compared with controls
(Student’s t-test for unpaired samples). n.d. = not determined. Values
for KC are taken from [11] and shown for easier comparison.
Fig. 2. Time dependence of rrC5a-induced prostanoid release from
cultured hepatic stellate cells. Experiments were performed essen-
tially as described in Fig. 1. Aliquots of the supernatant were taken
at the times indicated and increases in prostanoid concentrations
over basal levels at 0 min were determined by radio- or enzyme im-
munoassays. Values are means þ S.E.M. of 3 (TXB2) or 4 (PGD2
and PGE2) independent experiments. *P9 0.05, signi¢cant di¡eren-
ces compared with controls (Student’s t-test for unpaired samples).
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PGE2. This stimulation was almost maximal, since it could
not be enhanced signi¢cantly by high doses of rrC5a (1 WM)
(Fig. 3). Again, the dose dependence of rrC5a-induced pros-
tanoid release from hepatic stellate cells resembled that de-
scribed for Kup¡er cells [11]. Thus, also for hepatic stellate
cells, e¡ective rrC5a concentrations were similar to those of
about 100 nM reached in human serum after complete acti-
vation of the complement system [24]. As has been discussed
previously [11], the structural di¡erences between the recombi-
nant C5a used in this study and native C5a (12 additional N-
terminal amino acids (see Section 2) and lack of glycosylation
with the recombinant protein) did not cause major changes in
e⁄ciency.
The rrC5a-induced release of PGD2 and PGE2 from hepatic
stellate cells was completely inhibited to control levels by the
prostanoid synthesis inhibitor indomethacin (Table 1). It was
not in£uenced by pretreatment of the hepatic stellate cell cul-
tures with gadolinium chloride for 24 h (Table 1). This indi-
cates that prostanoid release from hepatic stellate cells could
not be ascribed to contaminating Kup¡er cells, since gadoli-
nium chloride, which was found to cause a functional deple-
tion of Kup¡er cells also in culture [25], inhibited the rrC5a-
elicited prostanoid release in Kup¡er cell cultures to about
45% (not shown). Three further observations corroborate
that prostanoid release from the hepatic stellate cell cultures
was not due to contaminating Kup¡er cells : (i) Contamina-
tion of hepatic stellate cell cultures with Kup¡er cells after
48 h was less than 2%, whereas the average prostanoid release
was 20% of that described for Kup¡er cells (Fig. 1). (ii) Sinus-
oidal endothelial cell cultures, which were contaminated
with Kup¡er cells to a similar degree as hepatic stellate cell
cultures, did not release signi¢cant amounts of PGD2 or
PGE2 after stimulation with rrC5a (Fig. 1). (iii) The prosta-
noid ratios released after stimulation with rrC5a clearly dif-
fered between hepatic stellate cells and Kup¡er cells (see
above).
3.3. Activation by rrC5a of glycogen phosphorylase in
cocultures of hepatic stellate cells with hepatocytes but not
in monocultures of hepatocytes
Since hepatocytes lack C5aR mRNA, it was assumed that
rrC5a might enhance glucose output in the perfused rat liver
indirectly via the release of prostanoids or of a ‘factor X’ from
the C5aR mRNA expressing non-parenchymal liver cells (see
Section 1). Therefore, it was investigated next whether rrC5a
activated glycogen phosphorylase not only in cocultures of
Kup¡er cells with hepatocytes as shown previously [11] but
also in cocultures of hepatic stellate cells or sinusoidal endo-
thelial cells with hepatocytes. In hepatic stellate cell/hepato-
cyte cocultures, rrC5a signi¢cantly activated glycogen phos-
phorylase. This activation was completely inhibited by
pretreatment of the cocultures with indomethacin (Fig. 4),
indicating that it was mediated by prostanoids only.
In a recent study it was shown that hepatocytes express
mRNA for the Gq-linked PGE2 receptor subtype 1 (EP1R)
and PGF2K receptor (FPR) but not TXA2 receptor (TPR)
[23]. Thus, PGE2 via the EP1R and PGF2K and PGD2 via
the FPR but not TXA2 can mediate an increase in inositol-
1,4,5-trisphosphate and intracellular Ca2 resulting in the ac-
tivation of glycogen phosphorylase in these cells [26^28]. Even
though Kup¡er cells and hepatic stellate cells di¡ered not only
in the ratios but also in the maximal amounts of prostaglan-
dins released (Fig. 1), rrC5a activated glycogen phosphorylase
in hepatic stellate cell/hepatocyte cocultures to a similar extent
as in Kup¡er cell/hepatocyte cocultures (Fig. 4). This might be
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Table 1
Inhibition of rrC5a-induced PGD2 and PGE2 release in isolated hepatic stellate cells by the prostanoid synthesis inhibitor indomethacin but
not by functional depletion of Kup¡er cells with gadolinium chloride
PGD2 release (% of rrC5a) PGE2 release (% of rrC5a)
0.7 þ 1.4 (5)* 18.0 þ 6.8 (5)*
rrC5a 100 (5) 100 (5)
rrC5a+indomethacin 2.9 þ 2.9 (3)* 1.4 þ 1.4 (3)*
rrC5a+gadolinium chloride 91.2 þ 25.2 (3) 118.5 þ 12.4 (3)
Hepatic stellate cells were isolated and cultured for 48 h with or without 10 WM gadolinium chloride during the last 24 h as described in Section 2.
Experiments were performed essentially as described in Fig. 1, except that cells were preincubated with 20 WM indomethacin where indicated.
Values are means þ S.E.M. of the number of experiments given in parentheses. *P9 0.001, signi¢cant di¡erence compared with rrC5a-stimulated
cells (Student’s t-test for unpaired samples). The e¡ectiveness of the pretreatment of the cells with gadolinium chloride was checked with Kup¡er
cell cultures: here rrC5a-induced PGDE2 and PGE2 release was inhibited to 45%.
Fig. 3. Dose-dependence of rrC5a-induced prostanoid release from
cultured hepatic stellate cells. Experiments were performed essen-
tially as described in Fig. 1. Cells were stimulated with the concen-
trations of rrC5a indicated. After 10 min supernatants were re-
moved and increases in prostanoid concentrations over basal levels
at 0 min were determined by radio- or enzyme immunoassays. Val-
ues are means þ S.E.M. of 4 independent experiments. *P9 0.05,
signi¢cant di¡erences compared with controls (Student’s t-test for
unpaired samples).
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explained by a stronger activation of glycogen phosphorylase
by PGE2, which is released in similar amounts by both cell
types, rather than by PGD2 or PGF2K. However, in the per-
fused rat liver PGF2K enhanced glucose output more strongly
than PGE2 or PGD2 [29] and in isolated hepatocytes PGE2
and PGF2K activated glycogen phosphorylase to similar ex-
tents [28]. Thus, more likely, the relatively small amounts of
prostaglandins released from hepatic stellate cells after stim-
ulation with rrC5a induced a maximal prostaglandin-depend-
ent activation of glycogen phosphorylase due to the paracrine
nature of their action.
RrC5a failed to induce glycogen phosphorylase activity in
sinusoidal endothelial cell/hepatocyte cocultures as well as in
hepatocyte monocultures (Fig. 4). This ¢nding demonstrates
that sinusoidal endothelial cells were not involved in rrC5a-
induced activation of glycogen phosphorylase neither by pros-
taglandins nor by any other ‘factor X’. Noradrenaline (1 WM),
which acts directly on hepatocytes, activated glycogen phos-
phorylase in all cocultures (not shown).
The ¢nding that rrC5a activated glycogen phosphorylase in
hepatic stellate cell/hepatocyte and Kup¡er cell/hepatocyte co-
cultures equally well supports the assumption that the remain-
ing C5a-induced metabolic and hemodynamic e¡ects in gado-
linium-treated rats [8] were due to non-parenchymal cells
other than Kup¡er cells and not to an incomplete functional
elimination of Kup¡er cells as has also been discussed in de-
tail previously [8]. Nevertheless, the experiments with isolated
cells do not allow a conclusion on the relative contribution of
Kup¡er cells and hepatic stellate cells to the anaphylatoxin-
induced glucose output in vivo. Di¡erences in (i) the accessi-
bility of anaphylatoxins to the Kup¡er cells and the hepatic
stellate cells within the liver tissue, (ii) the absolute amounts
of the various cells and (iii) the proximity of Kup¡er cells or
hepatic stellate cells to the hepatocytes must be taken into
account. The discrepancy that in gadolinium chloride-treated
rats the rrC5a-induced metabolic and hemodynamic e¡ects
were inhibited to only about 40%, whereas the prostanoid
over£ow was almost completely abrogated [8], might indicate
the involvement of other factors besides prostanoids released
from non-parenchymal liver cells in rrC5a-induced glucose
output. However, several observations rule out this possibil-
ity: (i) The activation of glycogen phosphorylase in cocultures
of Kup¡er cells or hepatic stellate cells with hepatocytes was
completely inhibited by the prostanoid synthesis inhibitor in-
domethacin. (ii) rrC5a did not induce glycogen phosphorylase
activity in sinusoidal endothelial cell/hepatocyte cocultures
(Fig. 4). (iii) The rrC5a-induced metabolic and hemodynamic
e¡ects in the perfused rat liver were completely inhibited by
indomethacin together with the thromboxane receptor antag-
onist daltroban (unpublished observations). Thus, the action
of rrC5a on glucose output was completely mediated by pros-
tanoids. Apparently, the over£ow of prostanoids into the hep-
atic vein did not re£ect the availability of prostanoids in the
Space of Disse for the hepatocytes. Taken together, the
present ¢ndings suggest that besides Kup¡er cells also hepatic
stellate cells are involved in C5a-induced glucose output in the
perfused rat liver. Final evidence that hepatic stellate cells
participate in the action of C5a on the liver would be pro-
vided by functional elimination of these cells analogously to
that of Kup¡er cells with gadolinium chloride. However, so
far such a method is not available.
4. Conclusions
Besides Kup¡er cells hepatic stellate cells also released pros-
taglandins and thromboxane in response to the anaphylatoxin
rrC5a in a time- and dose-dependent manner. Even though
hepatic stellate cells di¡ered from Kup¡er cells in the absolute
amounts and in the ratios of prostanoids released, glycogen
phosphorylase was activated to similar extents in cocultures of
hepatic stellate cells or Kup¡er cells with hepatocytes after
stimulation with rrC5a. Thus, the part of rrC5a-induced glu-
cose output in the perfused rat liver which was not inhibitable
by elimination of the Kup¡er cells with gadolinium chloride
most probably was due to rrC5a-induced prostanoid release
from hepatic stellate cells.
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